Rhabdomyolysis due to the additive effect of statin therapy and hypothyroidism: A case report

26Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We describe a patient with previously undiagnosed hypothyroidism who developed rhabdomyolysis while taking a statin. He had no other precipitating factors. The statin was stopped, intravenous fluids were started immediately and L-thyroxin was given after confirming the diagnosis of hypothyroidism. His symptoms improved over a few days. Because rhabdomyolysis is a rare but potentially life threatening disorder when complicated by acute tubular necrosis and renal failure, physicians must pay special attention when starting statins in patients with hyperlipidemia. © 2007 Yeter et al; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Yeter, E., Keles, T., Durmaz, T., & Bozkurt, E. (2007). Rhabdomyolysis due to the additive effect of statin therapy and hypothyroidism: A case report. Journal of Medical Case Reports, 1. https://doi.org/10.1186/1752-1947-1-130

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free